biopharmaceutical

Investments will support new product offerings, US expansion, and development of pathology foundation models. Aignostics, a global artificial…

Acticor Biotech, a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular…

InSilicoTrials, a leading provider of artificial intelligence (AI) and simulation tools for drug and medical device development, has embarked on a…

Lantern will leverage its proprietary AI platform, RADR, to rapidly develop novel cryptophycin-antibody drug conjugates (ADCs), which represent…

- New AI module delivers a "Target-to-T cell” approach for revolutionizing the identification and prioritization of targets for personalized antigen…

Scientist.com, the premier R&D marketplace for the biopharmaceutical industry, announced that its users can now buy off-the-shelf reagents, lab…

Cognizant announced it is working with Boehringer Ingelheim, a leading research-driven biopharmaceutical company, to advance the speed and quality of…

Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for…

Collaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial Execution Syneos Health, a leading fully integrated biopharmaceutical…

Lantern Pharma, a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform…